10
Participants
Start Date
October 20, 2023
Primary Completion Date
October 31, 2032
Study Completion Date
October 31, 2032
University of California, San Francisco, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
University of California, San Francisco
OTHER